Immunotherapy against metastatic renal cell carcinoma with mature dendritic cells

Abstract

We confirmed the safety of DC therapy in this clinical trial. The DTH test revealed that the DC therapy induced immunological response to RCC. On the other hand, it was necessary to reconsider the patient selection criteria.